Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06058429
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-26
First Post:
2023-09-21
Brief Title:
Immunogenicity of After Primary Immunization and Booster Immunization of sIPV
Sponsor:
Sinovac Biotech Co Ltd
Organization:
Sinovac Biotech Co Ltd
Study Overview
Official Title:
Immunogenicity After Primary Immunization and Booster Immunization of Sabin Strain Inactivated Polio Vaccine Vero Cells in Infants and Young Children and Enterovirus Serological Monitoring Study
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was conducted on the basis of Safety Observation of Sabin Strain Inactivated Polio Vaccine Vero Cell on primary Immunization Booster Immunization and Simultaneous Vaccination with Other Vaccines in Infants and Young ChildrenID PRO-sIPV-MA4001-JX Blood samples were collected in about 200 qualified subjects 1-9 months after their last vaccination of sIPV And immunogenicity of sIPV and other vaccines simultaneously administrated will be tested the antibodies against enterovirus including EV71CA16CA6 and CA10 will also be tested
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None